Key result
Left ventricular ejection fraction assessed by planar radionuclide ventriculography is a powerful independent predictor of 3-year mortality after primary percutaneous coronary intervention for STEMI.
Why the study?
Does left ventricular ejection fraction assessed by planar radionuclide ventriculography predict long-term mortality in patients treated with primary percutaneous coronary intervention for STEMI?
Cohort (n=925)
Yes
Does left ventricular ejection fraction assessed by planar radionuclide ventriculography predict long-term mortality in patients treated with primary percutaneous coronary intervention for STEMI?
Answers are grounded in this paper and cite their sources.
LVEF assessed by planar radionuclide ventriculography shortly after PPCI for STEMI is a powerful independent predictor of long-term all-cause mortality.
BACKGROUND: In the present study we sought to determine the long-term prognostic value of left ventricular ejection fraction (LVEF), assessed by planar radionuclide ventriculography (PRV), after ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PPCI). METHODS: In total 925 patients underwent PRV for LVEF assessment after PPCI for myocardial infarction before discharge from the hospital. PRV was performed with a standard dose of 500 Mbq of 99mTc-pertechnetate. Average follow-up time was 2.5 years. RESULTS: Mean (+/- SD) age was 60 +/- 12 years. Mean (+/- SD) LVEF was 45.7 +/- 12.2 %. 1 year survival was 97.3 % and 3 year survival was 94.2 %. Killip class, multi vessel-disease, previous cardiovascular events, peak creatin kinase and its MB fraction, age and LVEF proved to be univariate predictors of mortality. When entered in a forward conditional Cox regression model age and LVEF were independent predictors of 1 and 3 year mortality. CONCLUSION: LVEF assessed by PRV is a powerful independent predictor of long term mortality after PPCI for STEMI.
No takes yet. Share an insight, caveat, or question.
Vleuten et al. (2008) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=925). Left ventricular ejection fraction (LVEF) assessment was evaluated on 3-year mortality (HR 1.28, 95% CI 1.14-1.44, p=<0.001). Left ventricular ejection fraction assessed by planar radionuclide ventriculography is a powerful independent predictor of 3-year mortality after primary percutaneous coronary intervention for STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: